Wrapping up Q3 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including GoodRx ...
Key Insights Significant control over GoodRx Holdings by individual investors implies that the general public has ...
GoodRx is leveraging partnerships with Novo Nordisk and potential TrumpRx involvement to offset stagnating user growth and drive higher-margin revenue. Despite a 14% decline in Monthly Active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results